ALUMIS INC ALMS
COM · Common Stock · CUSIP 022307102
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersSouth San Francisco, CA
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $13.30.
Biggest buyers
| AyurMaya Capital Management Company, LP | New | +10.6m |
| Foresite Capital Management V, LLC | New | +5.6m |
| venBio Partners LLC | New | +2.8m |
| Cormorant Asset Management, LP | New | +2.1m |
| SR One Capital Management, LP | New | +2.0m |
| BAKER BROS. ADVISORS LP | New | +1.6m |
| Yu Fan | New | +789.6k |
| Omega Fund Management, LLC | New | +653.2k |
| Ally Bridge Group (NY) LLC | New | +618.8k |
| MORGAN STANLEY | New | +375.0k |
Biggest sellers
| None |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
Foresite Capital Fund VI LP
13D · may seek influence
-1.4 pts · filed 2026-04-03
Stated purposeThe Reporting Persons hold their securities of the Issuer for investment purposes. Depending on the factors discussed herein, the Reporting Persons may, from time to time, acquire additional shares of Common Stock and/or retain and/or sell all or a portion of the Common Stock held by the Reporting Persons in the open market or in privately negotiated transactions, and/or may distribute the Common Stock held by the Reporting Persons to their respective members or limited partners. Any actions the Reporting Persons might undertake will be dependent upon the Reporting Persons' review of numerous factors, including, among other things, the price levels of the Common Stock; general market and economic conditions; ongoing evaluation of the Issuer's business, financial condition, operations and p… Full filing |
12.7% |
| AyurMaya Capital Management Company, LP 13D · may seek influence -3.5 pts · filed 2026-07-02 | 12.3% |
| Deep Track Capital, LP 13G · passive investor new · filed 2026-04-07 | 6.0% |
| BlackRock, Inc. 13G · institution new · filed 2026-07-27 | 5.7% |
| FMR LLC 13G · institution new · filed 2026-08-06 | 5.5% |
| Samsara BioCapital, L.P. 13D · may seek influence +0.1 pts · filed 2026-01-13 | 5.4% |
Fell to 5% or below in the last year: venBio Global Strategic Fund IV, L.P. (4.8%, 2025-11-17)
Insider purchases and sales in Q2 2024
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q2 2024.
Holders, Q2 2024
| Manager | Shares | Change |
|---|---|---|
| AyurMaya Capital Management Company, LP 77.47% of their portfolio | 10.6m $141.6m | New |
| Foresite Capital Management V, LLC 47.43% of their portfolio | 5.6m $74.3m | New |
| venBio Partners LLC 16.23% of their portfolio | 2.8m $37.6m | New |
| Cormorant Asset Management, LP 1.66% of their portfolio | 2.1m $28.6m | New |
| SR One Capital Management, LP 8.16% of their portfolio | 2.0m $26.1m | New |
| BAKER BROS. ADVISORS LP 0.27% of their portfolio | 1.6m $20.8m | New |
| Yu Fan 13.72% of their portfolio | 789.6k $10.5m | New |
| Omega Fund Management, LLC 6.44% of their portfolio | 653.2k $8.7m | New |
| Ally Bridge Group (NY) LLC 4.90% of their portfolio | 618.8k $8.2m | New |
| MORGAN STANLEY 0.00% of their portfolio | 375.0k $5.0m | New |
| TOWERVIEW LLC 2.70% of their portfolio | 310.0k $4.1m | New |
| MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio | 253.8k $3.4m | New |
| NORGES BANK 0.00% of their portfolio | 250.0k $3.3m | Not comparable |
| SPHERA FUNDS MANAGEMENT LTD. 0.27% of their portfolio | 125.0k $1.7m | New |
| Iron Triangle Partners LP 0.17% of their portfolio | 125.0k $1.7m | New |
| VANGUARD GROUP INC 0.00% of their portfolio | 120.0k $1.6m | New |
| Hudson Bay Capital Management LP 0.00% of their portfolio | 37.5k $498.8k | New |
| Maven Securities LTD 0.05% of their portfolio | 25.0k $332.5k | New |
| Tetragon Partners GP Ltd 0.10% of their portfolio | 24.4k $323.9k | New |
| HRT FINANCIAL LP 0.00% of their portfolio | 21.1k $281.0k | New |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 20.9k $278.3k | New |
| Balyasny Asset Management L.P. 0.00% of their portfolio | 20.0k $266.0k | New |
| TWO SIGMA INVESTMENTS, LP 0.00% of their portfolio | 19.0k $252.7k | New |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 0.02% of their portfolio | 16.1k $213.8k | New |
| FIFTH LANE CAPITAL, LP 0.38% of their portfolio | 13.0k $172.9k | New |
| Eisler Capital (US) LLC 0.03% of their portfolio | 10.7k $142.9k | New |
| JANE STREET GROUP, LLC 0.00% of their portfolio | 10.2k $135.1k | New |
| Weiss Asset Management LP 0.01% of their portfolio | 10.0k $133.0k | New |
| SALEM INVESTMENT COUNSELORS INC 0.00% of their portfolio | 20 $266 | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | New |